Craneware Plc(LSE) CRW

Craneware plc is a leading provider of software solutions tailored for the U.S. healthcare industry. The company specializes in creating applications that enhance operational efficiency and revenue management for healthcare organizations.

Products and Services

• Chargemaster Toolkit for automated charge master administration
• Trisus Supply for data consistency across systems
• Physician Revenue Toolkit for performance oversight and billing management

Growth Outlook

• Revenue of $98.3 million reported in Q4 2026, showcasing strong demand
• Trailing twelve months (TTM) revenue growth indicates robust market positioning
• Continued investment in R&D supports future product innovation and expansion

Financial Highlights

• Net income of $9.5 million in Q4 2026, reflecting solid profitability
• TTM gross profit margin stands at 67.2%, indicating operational efficiency
• Dividend yield of 3.08% demonstrates commitment to shareholder returns

Craneware plc has established itself as a vital player in the healthcare software sector, focusing on solutions that streamline operations and enhance revenue capture for healthcare providers. The company's flagship products, such as the Chargemaster Toolkit and Physician Revenue Toolkit, are designed to address critical needs in charge management and billing oversight. Recent financial performance highlights a strong revenue base and profitability, with a notable net income reported in the latest quarter. The company's commitment to research and development positions it well for future growth, ensuring that it remains competitive in a rapidly evolving market. With a solid dividend yield, Craneware plc also demonstrates a commitment to returning value to its shareholders, making it an intriguing option for potential investors interested in the healthcare technology sector.